1 / 40

Stem Cells and Lineages: Mechanisms of Lung Development

Stem Cells and Lineages: Mechanisms of Lung Development. Overview of stages of lung development Epitheial-Mesenchymal interactions Budding Branching morphogenesis Sacularization and Alveolarization (Maturation) Genes and growth factors that control these processes

kael
Download Presentation

Stem Cells and Lineages: Mechanisms of Lung Development

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Stem Cells and Lineages: Mechanisms of Lung Development Overview of stages of lung development Epitheial-Mesenchymal interactions Budding Branching morphogenesis Sacularization and Alveolarization (Maturation) Genes and growth factors that control these processes Focus on how these molecules were shown to play a role in the processes

  2. Stem Cells and Lineages: Mechanisms of Lung Development Lungs did not develop from gills, they are a completely separate structrure Developed from swim bladders in fish Gills develop from pharyngeal arches independently of lungs.

  3. Bladder Early Late

  4. Review of mouse lung development Overview of mouse lung development Canalicular Alveolar Pseudoglandular Saccular Cordoso, Dev. Dyn. 219:121 (2000) Neonatology: SE Wert 5th edition 1999.

  5. Overview of mouse lung development Review of mouse lung development Canalicular Alveolar Pseudoglandular Saccular Cordoso, Dev. Dyn. 219:121 (2000) Neonatology: SE Wert 5th edition 1999.

  6. Summary of stages

  7. Nodal (TGF member) Foxa2, Sox17, GATA4,6, Stat3 needed for gut tube formation as shown by KOs Bladder Early Late

  8. Budding Evidence for players Tissue recombination experiments (70 years ago to today) In situ hybridization (guilt by assocation) Gene KOs and transgenics In vitro culture assays with beads and factors

  9. Tissue recombination experiments (70 years ago to today) Rudnick, D. 1933 Chick lung rudiments transplanted onto Chorioallantoic membranes and cultured. Mesenchyme required for branching. Wessells, N 1970 Lung buds form opposite sites where lung mesenchyme is placed in vitro. Masters, JRW 1976 Mesenchyme is needed to induce branching morphogenesis in vitro from tracheal buds. Shannon, JM 1994 Distal mesenchyme can induce bud and branching of proximal trachea

  10. Shannon, JM 1994 Distal mesenchyme can induce bud and branching of proximal trachea

  11. Shannon, JM 1994 Distal mesenchyme can induce bud and branching of proximal trachea Day 13 lung Grafted Trachea time 0 Grafted Trachea 24hrs

  12. Shannon, JM 1994 Distal mesenchyme can induce bud and branching of proximal trachea

  13. Shannon, JM 1994 Distal mesenchyme can induce bud and branching of proximal trachea Get relatively normal looking lung lobes when mesenchyme is grafted next to trachea. What are inducing molecules from normal E9-9.5 gut mesenchyme that induce budding? FGF10 is believed to be the primary bud inducing molecule. Retinoic acid receptors are also implicated in initial lung formation as double KOs of 2 prevent trachea formation.

  14. Evidence for FGF10? Is expressed in mesenchyme opposite where lung bud forms. KO of FGF10 prevents budding and lung formation. Little else known about bud formation How is FGF10 localized? What target genes are there in the epithelium that respond to FGF10?

  15. Branching morphogenesis • FGF10, TTF-1, Shh other molecules in a repeating signalling network during branching • Evidence primarily from KOs and explant studies

  16. Branching morphogenesis FGF9-Shh network also implicated in early branching. KO reduces branching. Foxa1 or Foxa2 needed for Shh expression in epithelium Development 133, 1507-1517 (2006) doi:10.1242/dev.02313

  17. Branching lineage

  18. Genetic control of branching lineage Spry2 (Sprouty 2) a member of a tyrosine kinase inhibitor family. Ectopic domain branching in Spry22/2 mutants. a, The RCd lobe (ventral view) of an E12.5 control (Spry21/2) lung with a single secondary branch (V1, circled) off RCd, at the level of RCd.L4 (L4). Below, RCd.V1 lineage and schematic of RCd with a single ventral secondary branch (V1). b, Same view of an E12.5 Spry22/2 lung showing the normal ventral secondary branch (V1) and an ectopic branch (V*) that forms earlier and proximal to V1. V* has already sprouted additional generations of branches. Below, lineage and schematic show V* plus additional ectopic ventral branches (V**, V***; dashed lines in schematic) seen in other Spry22/2 lungs (Supplementary Fig.4). Scale bar (for a and b), 200 mm.

  19. Genetic control of branching • Shh (Epith.), Hip1, Ptc1,Gli2, Gli3 (mesen.) • FGF10, FGF9 (mesen.) • TTF-1 aka Titf1 (Epith.) • Foxa1+Foxa2, single KOs branch normally req. for Shh expression in epith. • BMP4 (Tgf family) (mesen.) • Pod1 (bHLH TF in mesen.) • -catenin signalling in epith. And mesen. • Foxf1 (mesen.) • Tbx4, 5 req. for Fgf10 express. in mesen. (siRNA studies) • Hoxa5 (mesen.) • Spry2 FGF tyrosine kinase inhibitor (Epith.)

  20. Genetic control of branching Reciprocal Epithelial-Mesenchymal interactions mediated by growth factor- and cell contact-regulated transcriptional networks. These interactions both constitute a program of growth, morphogenesis and differentiation and then help establish the quazi-stable epigenetic states that characterize each differentiated cell.

  21. Overview of mouse lung development Review of mouse lung development Canalicular Alveolar Pseudoglandular Saccular Cordoso, Dev. Dyn. 219:121 (2000) Neonatology: SE Wert 5th edition 1999.

  22. Canalicular and saccular phases(later maturation E16.5-P5) • Transition from undifferentiated to fully differentiated cells and marked reduction in cell proliferation. • KOs, conditional KOs and conditional transgenics • In vitro culturing of lungs

  23. Canalicular phase (E16.5-17.5)what cell types are formed in conducting airways? Foxj1 KO eliminates cilia on cells p63 KO eliminates basal cells Gfi-1 KO reduces number of PNECs

  24. Early Saccular phase (E17.5-E18.5) Hypoplastic versus hyperplastic lungs • Coupling of redued cell proliferation to increased cell differentiation • Some mutants have smaller lungs that are "immature", other mutants have larger lungs that are "immature" • Maturation measured by terminal differentiation markers in Type II and Type I epithelial cells.

  25. Saccular phase (E17.5-P5)Nfib (hyperplastic) Lung defects in Nfib-/- and +/- E17.5 animals -/- E17.5 lungs look like E15.5 lungs suggests maturation defect

  26. Increased DNA content inE18.5 Nfib-/- lungs ~4X increased PCNA levels inE18.5 Nfib-/- lungs (RT-QPCR)

  27. Loss of differentiation markers reflect immaturity in Nfib-/- lungs (RT-QPCR)

  28. Saccular phase (E17.5-P5)TGFb3 KO (hypoplastic) E18.5 +/+ -/- +/+ -/-

  29. Saccular phase (E17.5-P5)TGFb3 KO (hypoplastic) E18.5loss of diffn. markers -/-

  30. Early Saccular phase (E17.5-E18.5) Hypoplastic versus hyperplastic lungs • Coupling of reduced cell proliferation to increased cell differentiation can be affected differently in different mutants. • Maturation measured by terminal differentiation markers in Type II and Type I epithelial cells. Some mutations affect expression or proliferation of both cells types, some only one. • How many maturation programs are there and how are they linked?

  31. Saccular phase (E17.5-P5)Control of epithelial differentiation I

  32. Nfib Saccular phase (E17.5-P5)Control of epithelial differentiation II This leaves out NFI, GR, Gata6, SP3, Sox11, HIF2A, TGF3 and other TFs and GFs that affect maturation.

  33. Alveolarization (P5-P28) • Terminal differentiation of type I cells • Further reduction in mesenchyme • Increased surfactant expression in type II cells • Expansion of saccules into alveoli with septation

  34. Just so you don't think it's too simple

  35. Just so you don't think it's too simple

  36. Just so you don't think it's too simple

  37. Just so you don't think it's too simple Things we left outVasculatureRepair of damageLung Stem CellsLung diseasesImmune responses

  38. Review of mouse lung development Overview of mouse lung development Canalicular Alveolar Pseudoglandular Saccular Cordoso, Dev. Dyn. 219:121 (2000) Neonatology: SE Wert 5th edition 1999.

  39. Overview of mouse lung development Review of mouse lung development Canalicular Alveolar Pseudoglandular Saccular Cordoso, Dev. Dyn. 219:121 (2000) Neonatology: SE Wert 5th edition 1999.

  40. How to build an organ Reciprocal Epithelial-Mesenchymal interactions mediated by growth factor- and cell contact-regulated transcriptional networks. These interactions both constitute a program for growth, morphogenesis and differentiation and then help establish the quazi-stable epigenetic states that characterize each differentiated cell. Many organs follow this strategy with the addition of other processes such as cell-recruitment, Epithelial-Mesenchymal transitions (EMT) and Mesenchymal-Epithelial transitions (MET).

More Related